IP Library Patent Application 17769197
Patent Application
App. No. 17/769,197

TERMINAL AND RADIO COMMUNICATION METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/769,197
Abstract

A terminal according to one aspect of the present disclosure includes a control section that, when a reference signal for pathloss reference for a certain uplink signal is not configured, calculates a pathloss for the certain uplink signal by using a reference signal for quasi co-location (QCL) of a certain downlink resource and determines transmission power of the certain uplink signal based on the pathloss, and a transmitting section that transmits the certain uplink signal by using the transmission power.

Claims (23)

1 .- 6 . (canceled)

7 . A terminal comprising:

a receiver that receives information regarding transmission configuration indication (TCI) state; and

a processor that uses a reference signal of type D in the TCI state for a spatial relation for a sounding reference signal (SRS) and a pathloss estimation for the SRS, when a first higher layer parameter for default beam for the SRS is configured, a second higher layer parameter for spatial relation information for the SRS except for a beam management usage in a certain frequency region is not configured and a third higher layer parameter for a reference signal for pathloss reference for the SRS is not configured.

8 . The terminal according to claim 7 , wherein when one or more control resource sets are configured in a component carrier of the SRS, the TCI state is a TCI state of a control resource set with a lowest control resource set ID among the one or more control resource sets.

9 . The terminal according to claim 7 , wherein when any control resource set is not configured in a component carrier of the SRS, the TCI state is an activated TCI state with a lowest ID applicable to a physical downlink shared channel (PDSCH) in the component carrier.

10 . The terminal according to claim 7 , wherein when a number of the reference signal used for the pathloss estimation is configured more than a certain number, the processor does not perform the pathloss estimation for a reference signal in excess of the certain number.

11 . A radio communication method for a terminal comprising:

receiving information regarding transmission configuration indication (TCI) state; and

using a reference signal of type D in the TCI state for a spatial relation for a sounding reference signal (SRS) and a pathloss estimation for the SRS, when a first higher layer parameter for default beam for the SRS is configured, a second higher layer parameter for spatial relation information for the SRS except for a beam management usage in a certain frequency region is not configured and a third higher layer parameter for a reference signal for pathloss reference for the SRS is not configured.

12 . A base station comprising:

a transmitter that transmits information regarding transmission configuration indication (TCI) state; and

a processor that controls a reception of a sounding reference signal (SRS) to which a spatial relation and a pathloss is applied, when a first higher layer parameter for default beam for the SRS is configured, a second higher layer parameter for spatial relation information for the SRS except for a beam management usage in a certain frequency region is not configured and a third higher layer parameter for a reference signal for pathloss reference for the SRS is not configured,

wherein the spatial relation and the pathloss are based on a reference signal of type D in the TCI state.

13 . A system comprising a terminal and a base station, wherein:

the terminal comprises:

a receiver that receives information regarding transmission configuration indication (TCI) state; and

a processor that uses a reference signal of type D in the TCI state for a spatial relation for a sounding reference signal (SRS) and a pathloss estimation for the SRS, when a first higher layer parameter for default beam for the SRS is configured, a second higher layer parameter for spatial relation information for the SRS except for a beam management usage in a certain First Preliminary Amendment frequency region is not configured and a third higher layer parameter for a reference signal for pathloss reference for the SRS is not configured; and

the base station comprises:

a transmitter that transmits the information regarding the TC state; and

a receiver that receives the SRS.

14 . The terminal according to claim 8 , wherein when a number of the reference signal used for the pathloss estimation is configured more than a certain number, the processor does not perform the pathloss estimation for a reference signal in excess of the certain number.

15 . The terminal according to claim 9 , wherein when a number of the reference signal used for the pathloss estimation is configured more than a certain number, the processor does not perform the pathloss estimation for a reference signal in excess of the certain number.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0737 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2022
From: MATSUMURA, YUKI; NAGATA, SATOSHI
To: NTT DOCOMO, INC.
Reel/Frame 059884/0434 →